Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Teladoc Health Inc banner

Teladoc Health Inc
NYSE:TDOC

Watchlist Manager
Teladoc Health Inc Logo
Teladoc Health Inc
NYSE:TDOC
Watchlist
Price: 9.55 USD -1.75%
Market Cap: $1.7B
Write Note Create Alert Ask AI

Wall St Price Targets

TDOC Price Targets Summary
Teladoc Health Inc

Wall Street analysts forecast TDOC stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TDOC is 7.4 USD with a low forecast of 5.05 USD and a high forecast of 10.5 USD.

TDOC Lowest Forecast
5.05 USD
-47% Downside
TDOC Average Forecast
7.4 USD
-23% Downside
TDOC Highest Forecast
10.5 USD
10% Upside
Lowest Forecast
Price Target
5.05 USD
47% Downside
Average Forecast
Price Target
7.4 USD
23% Downside
Highest Forecast
Price Target
10.5 USD
10% Upside
Teladoc Health Inc Competitors:
Price Targets
DRT
DIRTT Environmental Solutions Ltd
84% Upside
CIM
Chimera Investment Corp
16% Upside
MGNX
MacroGenics Inc
70% Upside
BBW
Build-A-Bear Workshop Inc
75% Upside
DRT
DIRTT Environmental Solutions Ltd
84% Upside
CIM
Chimera Investment Corp
16% Upside
MGNX
MacroGenics Inc
70% Upside
BBW
Build-A-Bear Workshop Inc
75% Upside
WHF
WhiteHorse Finance Inc
21% Upside
AEVA
Aeva Technologies Inc
55% Upside

Revenue
Forecast

45% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
45% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 11 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 6 years is 2%.

What are analyst estimates?

Gross Profit
Forecast

43% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
43% / Year
Past Growth
2% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 11 years, the compound annual growth rate for Gross Profit has been 43%. The projected CAGR for the next 6 years is 2%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

What are analyst estimates?

Continue TDOC Research

Summary
TDOC intrinsic value, competitors valuation, and company profile.
DCF Valuation
TDOC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TDOC stock valuation using valuation multiples.
Wall St Estimates
TDOC price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TDOC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Teladoc Health Inc listings:
LSE • USD
0LDR
 F • EUR
4LL
 SWB • EUR
4LL
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TDOC's stock price target?
Price Target
7.4 USD

According to Wall Street analysts, the average 1-year price target for TDOC is 7.4 USD with a low forecast of 5.05 USD and a high forecast of 10.5 USD.

What is the Revenue forecast for Teladoc Health Inc?
Projected CAGR
2%

Over the last 11 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 6 years is 2%.

What is the Gross Profit forecast for Teladoc Health Inc?
Projected CAGR
2%

Over the last 11 years, the compound annual growth rate for Gross Profit has been 43%. The projected CAGR for the next 6 years is 2%.

Back to Top
ALPHA SPREAD
Follow us
Join 348,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett